0001140361-18-010828.txt : 20180228
0001140361-18-010828.hdr.sgml : 20180228
20180228164506
ACCESSION NUMBER: 0001140361-18-010828
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180226
FILED AS OF DATE: 20180228
DATE AS OF CHANGE: 20180228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KARSEN PERRY A
CENTRAL INDEX KEY: 0001260573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35993
FILM NUMBER: 18651872
MAIL ADDRESS:
STREET 1: C/O CELGENE CORPORATION
STREET 2: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001302573
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 383572512
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-995-8200
MAIL ADDRESS:
STREET 1: 800 CHESAPEAKE DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc1.xml
FORM 4
X0306
4
2018-02-26
0
0001302573
OncoMed Pharmaceuticals Inc
OMED
0001260573
KARSEN PERRY A
C/O ONCOMED PHARMACEUTICALS, INC.
800 CHESAPEAKE DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2018-02-26
4
A
0
70500
0.00
A
80500
D
Stock Option (Right to Buy)
2.29
2018-02-26
4
A
0
120000
0.00
A
2028-02-26
Common Stock
120000
120000
D
Grant of Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock of the issuer for each one (1) RSU upon the vesting thereof.
The option vests with respect to 1/6 of the shares subject thereto on each monthly anniversary of January 3, 2018, subject to the Reporting Person's continued service to the Issuer as Executive Chairman through each such vesting date.
/s/ Alicia Hager, Attorney-in-Fact for Perry A. Karsen
2018-02-28